非经常性损益

港股IPO招股书披露先例 · 311 家公司,348 项

非经常性损益指一次性或非经常发生并影响期间业绩的事项,如廉价购买收益、出售收益、大额汇兑损益及政府补助增减等。申请人一般在概要、业务、财务资料及风险因素章节披露其性质、金额及对毛利率、其他收入等指标的影响,并说明剔除一次性项目后的基线、相关事项不再重现或补偿负债已结清,将波动归因于业务性质、汇率波动或战略举措。

2026-06-30Prospectus
合肥晶合集成电路股份有限公司NEXCHIP SEMICONDUCTOR (CHINA) LIMITED02249.HK

2025年确认光罩技术转让收入2.773亿元

In September 2025, as part of the optimization of our business strategy, we entered into a photomask technology transfer agreement with our associate, Anhui Jingmei Photomasks Ltd. (安徽晶鎂光罩有限公司) (“Anhui Jingmei”).

Financial Information · 第 189 页

Our other income increased by 45.1% from RMB327.3 million in 2024 to RMB475.0 million in 2025, primarily due to the recognition of a technology transfer income in relation to our photomask technology transfer in 2025, partially offset by the decrease in interest income in line with the decreases in our bank deposits.

Financial Information · 第 194 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-30Application Proof
四川远海国际旅行社股份有限公司Hiseas International Tourism Group

2024年确认税亏致所得税抵减940万元

We recorded income tax credit of RMB9.4 million for 2024, primarily because we recognized the previously unrecognized tax losses in 2024.

Financial Information · 第 191 页

We recorded income tax expenses of RMB1.3 million for 2023 and income tax credit of RMB9.4 million for 2024, as we utilized the previously unrecognized tax losses in 2024.

Financial Information · 第 193 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-30Prospectus
广东鼎泰高科技术股份有限公司Guangdong Dtech Technology Co., Ltd.01377.HK

2023年一次性税收返还致其他收益下降

During the Track Record Period, our government grants decreased from RMB33.0 million in 2023 to RMB10.6 million in 2024, and remained relatively stable at RMB10.2 million in 2025.

Financial Information · 第 219 页

Such fluctuation was primarily attributable to the receipt of a relatively significant tax rebate from local government authorities under applicable local preferential policies in 2023, which was one-off in nature.

Financial Information · 第 219 页

Our other income decreased by 43.1% from RMB75.4 million in 2023 to RMB42.9 million in 2024, primarily due to (i) a decrease in government grants, (ii) a decrease in interest income and (iii) a decrease in sales of scrap materials.

Financial Information · 第 226 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-30Prospectus
滨化集团股份有限公司Befar Group Co., Ltd06745.HK

其他收益及亏损波动影响业绩

For the year ended December 31 2024, we recorded other losses of RMB148.2 million, as compared to other gains of RMB40.9 million for the year ended December 31, 2023.

Financial Information · 第 239 页

(ii) an increase in foreign exchange losses, mainly due to the commissioning of some of our C3-C4 facilities, which led to an increasing procurement of imported raw materials and, in turn, an increase in the amount of foreign exchange purchase.

Financial Information · 第 239 页

For the year ended December 31, 2025, we recorded other gains of RMB44.7 million, compared to a loss of RMB148.2 million for the year ended December 31, 2024.

Financial Information · 第 237 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-30Application Proof
龙迅半导体(合肥)股份有限公司Lontium Semiconductor Corporation

2025年政府补贴减少致其他收入及收益下降

Our net other income and gains decreased by 14.7% from RMB43.6 million in 2024 to RMB37.1 million in 2025, primarily due to the decrease in government grants of RMB5.8 million, mainly attributable to the phasing out of certain subsidy programs and timing differences in the renewal of government grants.

Financial Information · 第 154 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-30Application Proof
深圳市道通科技股份有限公司Autel Intelligent Technology Corp., Ltd.

2023年和解付款、拨备及2024年处置收益等一次性项目

We reached a settlement in an arbitral proceeding and agreed to pay a settlement amount of RMB237,216,000, of which RMB16,019,000 had been recorded as a provision before 2023.

Financial Information · 第 168 页

Based on the progress of a legal proceeding, we made a provision for litigation compensation in 2023. In January 2026, we prevailed in the final verdict. As this favorable outcome constitutes a subsequent event that requires adjustment, we reversed the provision in 2025.

Financial Information · 第 168 页

We recorded other net gains of RMB86.7 million in 2024, as compared with other net losses of RMB225.4 million in 2023, which was primarily attributable to (i) the absence in 2024 of the one-off settlement payment and litigation provision recognized in 2023, and (ii) the recognition in 2024 of remeasurement gains in relation to the loss of control over a subsidiary and gains from disposal of subsidiaries, partially offset by higher factoring costs for trade receivables and lower net foreign exchange gains.

Financial Information · 第 168 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-30Application Proof
科郦有限公司COREE Company Limited

北京韩美咨询费安排终止致其他收入骤降

In 2023, 2024 and 2025, our consulting fee income attributable to Beijing Hanmi amounted to USD26.1 million, USD12.4 million and nil, respectively, representing approximately 93.0%, 91.7% and nil of our total consulting fee income, respectively.

Financial Information · 第 184 页

Pursuant to the relevant market promotion services agreement and the corresponding termination agreement, our operational management assistance and consultation services to Beijing Hanmi were terminated with effect from July 1, 2024.

Financial Information · 第 185 页

Our other income decreased significantly by 83.9% from USD18.0 million in 2024 to USD2.9 million in 2025, primarily due to a reduction in consulting fee income.

Financial Information · 第 189 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-30Application Proof
广州豪特节能环保科技股份有限公司Guangzhou Haote Energy Saving Technology Co., Ltd.

2024年全额减值2500万元项目保证金

In 2024, we paid a construction deposit of RMB25.0 million to a contracted customer for the purpose of performing the contract for an energy management solution project with a total contract value of RMB800.0 million.

Financial Information · 第 237 页

However, the contracted customer did not commence the project according to the prescribed timeframe, and, despite repeated requests, has not repaid the deposit to the Company.

Financial Information · 第 237 页

As a result, we considered the credit risk to have increased significantly since initial recognition;

Financial Information · 第 237 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-30Application Proof
成都欧林生物科技股份有限公司Chengdu Olymvax Biopharmaceuticals Inc.

2023年获850万元上市相关一次性政府补助

This improvement was partially offset by a decrease in government grants from RMB15.8 million to RMB10.1 million, as we received certain large, non-recurring subsidies in 2023, such as an RMB8.5 million award related to our initial public offering on the SSE STAR Market.

Financial Information · 第 238 页

While we receive certain smaller subsidies on a recurring basis, our government grants are primarily non-recurring in nature and are tied to the achievement of specific milestones, such as the initial public offering and listing of our A Shares on the SSE STAR Market, or are designated for particular projects.

Financial Information · 第 231 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-30Prospectus
珞石(山东)机器人集团股份有限公司ROKAE (SHANDONG) ROBOTICS GROUP INC.03752.HK

2023年赎回负债修改一次性收益

Our other gains decreased by 36.2% from RMB14.2 million in 2023 to RMB9.1 million in 2024, primarily due to the recognized RMB13.9 million one-off gain from the modification of redemption liabilities in 2023, in relation to the deferral of exercise date of the redemption rights, partially offset by an increase of RMB8.7 million of fair value changes of financial assets at FVTPL.

Financial Information · 第 237 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-29Application Proof
北京盛景网联科技服务股份有限公司Beijing Shengjing Wanglian Science and Technology Service Co., Ltd.

2024年出售子公司导致净其他亏损约630万元

We recorded net other losses of approximately RMB6.3 million in 2024 as compared to net other gains of approximately RMB46.0 thousand in 2025, primarily due to the losses on disposal of subsidiaries arising from disposal of Changxing Jiacheng and Hainan Shengyi in 2024, whereas no such incident occurred in 2025.

Financial Information · 第 220 页

We recorded net other gains of approximately RMB3.1 million in 2023 as compared to net other losses of approximately RMB6.3 million in 2024, primarily due to in 2023, (i) an increase in gains on disposal of subsidiaries following the disposal of Peakview Capital Management Co., and (ii) a decrease in gains on disposal of early lease termination and other modifications.

Financial Information · 第 222 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-29Application Proof
北京盛景网联科技服务股份有限公司Beijing Shengjing Wanglian Science and Technology Service Co., Ltd.

2025年政府补助大增带动其他收入升至420万元

During the Track Record Period, we recorded other income of approximately RMB1.0 million, RMB0.4 million and RMB4.2 million for the years ended 31 December 2023, 2024 and 2025, respectively.

Financial Information · 第 216 页

Our other income increased from approximately RMB0.4 million in 2024 to approximately RMB4.2 million in 2025, primarily due to an increase in government grant in 2025 following the government's approval of a grant upon verification of our Company's and our fund's local tax contributions in Hangzhou, as applied for by Hangzhou Shengyi in accordance with relevant local policies.

Financial Information · 第 220 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-29Prospectus

2023年确认6,000万元一次性政府补助后回落

Government grants of RMB60.0 million with certain performance conditions attached was recognized in deferred income when received and was recognized as other income in 2023 when the performance conditions have been fulfilled.

Financial Information · 第 261 页

Our other income decreased significantly by 84.1%, from RMB68.2 million in 2023 to RMB10.9 million in 2024. This decline was primarily due to the absence of certain non-recurring income items recognized from deferred income recorded in the prior period.

Financial Information · 第 268 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-29Application Proof

2024年一次性商标授权收入

In January 2024, we licensed such trademark and copyright to the OEM supplier and offline trading partner of such infant formula to facilitate the distribution of such infant formula, in exchange for a one-off royalty fee of RMB6.6 million.

Financial Information · 第 224 页

Our other income and gains further decreased in 2025, primarily due to (i) lower investment income realized from our investments in wealth management products and time deposits; (ii) decreased income from licensing out of a trademark as we did not record similar income in 2025; and (iii) lower bank interest income, which is in line with decreased current bank balances in 2025.

Financial Information · 第 224 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-29Prospectus
深圳基本半导体股份有限公司BASiC Semiconductor Co., Ltd.09971.HK

政府补助波动致其他收入大幅变动

Our other income and gains increased by 446.8% from RMB4.9 million in 2023 to RMB26.7 million in 2024, primarily due to the significant increase in government grants because (i) a significant amount of government grants became qualified to be transferred from deferred income to other income and gains, as our projects with government grants were completed in 2024; and (ii) we received a larger amount of government grants that could be directly recognized as other income and gains in 2024.

Financial Information · 第 243 页

Our other income and gains decreased by 50.9% from RMB26.7 million in 2024 to RMB13.1 million in 2025, primarily because (i) a greater portion of government grants was recognized as other income and gains, as more projects associated with these grants were completed in 2024 compared to 2025, allowing for the transfer of a larger amount from deferred income; and (ii) we received a smaller amount of government grants that could be directly recognized as other income and gains in 2025.

Financial Information · 第 241 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-26Application Proof
复星安特金(成都)生物制药股份有限公司Fosun Adgenvax (Chengdu) Biopharmaceutical Co., Ltd.

非经常性因素致销售成本高企

In 2023, 2024 and 2025, our cost of sales amounted to RMB107.8 million, RMB67.7 million and RMB159.1 million, respectively, representing 33.2%, 83.3% and 30.3% of total revenue. A substantial portion of such cost of sales was incurred due to non-recurring factors.

Business · 第 155 页

The substantial cost of sales in 2023 was primarily attributable to (i) idle costs, which amounted to RMB23.3 million in 2023 and reduced to nil in 2024.

Business · 第 155 页

We consider this timing gap to be transitory in nature and expect it to narrow progressively as revenue from our newly launched products scales with deepening CDC network penetration.

Business · 第 156 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-26Prospectus
北京同仁堂医养投资股份有限公司Beijing Tong Ren Tang Healthcare Investment Co., Ltd.02667.HK

处置收益及或有对价重估致其他收入波动

Our net other income and gains increased by 47.3% from RMB19.5 million for the year ended December 31, 2023 to RMB28.7 million for the year ended December 31, 2024, as we recorded gains on our disposal of Shijiazhuang TRT TCM Hospital and gains on revaluation of contingent consideration in relation to the performance commitments of San Xi Tang, which was partially offset by the cessation of receiving concession income of Beijing Jufang after our transfer of the organizer’s interests in Hujialou Second Community Healthcare Center in June 2023.

Financial Information · 第 256 页

Representing the revaluation of performance-based compensation determined according to the performance commitment provisions under the share transfer agreements.

Financial Information · 第 251 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-26Application Proof
浙江新瑞立汽配股份有限公司Zhejiang New SORL Auto Parts Co., Ltd.

2024年汇兑收益640万元及2025年汇兑损失

Our foreign exchange gains amounted to RMB6.4 million in 2024, primarily driven by substantial USD-denominated revenue and favorable movement in the USD/CNY exchange rate.

Financial Information · 第 186 页

The decrease was primarily due to (i) lower bank interest income; and (ii) foreign exchange gains realized in 2024, as opposed to foreign exchange losses recorded under “other expenses” in 2025.

Financial Information · 第 189 页

Such investment income rose from RMB0.6 million in 2023 to RMB5.3 million in 2024, and declined to RMB2.1 million in 2025, primarily due to the fluctuations of foreign exchange rates.

Financial Information · 第 185 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-26Application Proof
大秦数字能源技术股份有限公司Dyness Digital Energy Technology Co., Ltd.

2025年汇兑收益5,934万元推高其他净收入

Our other net income increased by 156.9% from RMB34.6 million in 2024 to RMB89.0 million in 2025, primarily due to (i) a shift in foreign exchange from losses of RMB0.7 million in 2024 to gains of RMB59.3 million in 2025, mainly driven by the appreciation of the euro in 2025, and (ii) an increase in government grants from RMB12.6 million in 2024 to RMB16.5 million in 2025, partially offset by a decrease in bank interest income from RMB16.8 million in 2024 to RMB11.6 million in 2025.

Financial Information · 第 195 页

Our other net income primarily consists of (i) bank interest income, (ii) government grants, (iii) net realized or unrealized gains on financial assets measured at FVPL and (iv) net foreign exchange gain/(loss).

Financial Information · 第 188 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-25Application Proof
神基制药有限公司NeuroGen Pharma Limited

2025年确认净汇兑损失1,550万元

Our Group recorded other net losses of RMB17.8 million in 2025, primarily consisting of net foreign exchange losses of RMB15.5 million mainly caused by fluctuations in the USD exchange rate.

Financial Information · 第 229 页

Net foreign exchange gains/(losses) | (41) | 0.9 | (20) | 0.9 | (47) | 1.7 | 2,380 | 99.7 | (15,484) | 87.2

Financial Information · 第 225 页

Our Group recorded other net gains of RMB2.4 million in the 2024 Period, primarily representing the net foreign exchange gain arising primarily from USD-denominated balances.

Financial Information · 第 230 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看

Tell us